Background: Patent foramen ovale (PFO) is a remnant of the fetal circulation present in 20% of the population. Right-to-left shunting (RLS) through a PFO has been linked to the pathophysiology of stroke, migraine with aura, and hypoxemia. While different imaging modalities including transcranial Doppler, intra-cardiac echo, and transthoracic echo (TTE) have often been used to detect RLS, trans-esophageal echo (TEE) bubble study remains the gold standard for diagnosing PFO. The aim of this study was to determine the relative accuracy of TEE in the detection of PFO. Methods and Results: A sys-tematic review of Medline, using a standard approach for metaanalysis, was performed for all prospec-tive studies assessing accuracy of TEE in the detection of PFO using confirmation by autopsy, cardiac surgery, and/or catheterization as the reference. Search results revealed 3105 studies; 4 met inclusion criteria. A total of 164 patients were included. TEE had a weighted sensitivity of 89.2% (95% CI: 81.1-94.7%) and specificity of 91.4% (95% CI: 82.3-96.8%) to detect PFO. The overall positive likelihood ratio (LR+) was 5.93 (95% CI: 1.30-27.09) and the overall negative likelihood ratio (LR ) was 0.22 (95% CI: 0.08-0.56). Conclusion: While TEE bubble study is considered to be the gold standard modality for diagnosing PFO, some PFOs may still be missed or misdiagnosed. It is important to understand the limitations of TEE and perhaps use other highly sensitive screening tests, such as trans-cranial doppler (TCD), in conjunction with TEE before scheduling a patient for transcatheter PFO closure. (Echocardiography2014; 31:752-758) Key words: patent foramen ovale, TEE, echocardiography Background: Patent foramen ovale (PFO) is a remnant of the fetal circulation present in 15-35% of the general population based on autopsy and imaging studies. [1] [2] [3] [4] While most people with a PFO remain asymptomatic, some develop medical syndromes that can be chronic and debilitating. Transient right-to-left shunting (RLS), usually through a PFO, has currently been linked to cryptogenic stroke, migraine with aura, acephalgic migraine, sleep apnea, platypneaorthodeoxia, and decompression illness.
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A meta-analysis of observational studies and the combined data from the CLOSURE 1, RESPECT, and PC Trials suggest that PFO occluding devices reduce the recurrence of 2 stroke and transient ischemic attack at higher rates than conventional medicaltreatmentalone (pooled HR 0.59, 95% CI 0.36-0.97; P=0.04). To assess between-study heterogeneity (other than threshold effect)andbetween-study inconsistency, the CochranQs t a t i s t i c , a n d t h e i n c o n s i s t e n c y i n d e x ( I 2 ) were calculated, respectively, and the level ofs i g n i fi-cance for the corresponding P-value was setatP=0.10.
Due to anticipated inter-study hetero-geneity, a random effects analysis model (DerSi-monian-Laird) 20 was used for this meta-analysis because it provides more conservative estimates of the pooled data. sROC were constructed using the DerSimonian-Laird random effectsmodel.The area under the curve (AUC) and indexQ*were used to assess and summarize the discrimi-nating ability of the sROC curve. Figure 1 describes the study selection method used for thisanalysis.
QualityAssessment:
Using the recommended 14-item checklistforevaluating imaging studies using QUADAS,items2, 5, 8, 9, and 11 either were scored poorlyorwereconsideredunclear:item2("se lectioncrite-ria described?"), item 5 ("partial verification avoided?"), item 8 ("index test described in detailtopermitreplication?"),item9("refer ence standard described in detail to permit replica-tion?"), and item 11 ("reference standardresults blinded?"). When assessing for selection criteria (i.e. item 2), one study failed to clearly define their inclusion criteria when selectingparticipants.Re g ardi ngi te m 5 w hi ch i s u se d to avoid Figure 1 .Selection of studies. selection bias, in 2 studies not all participants underwent the reference standard test. Inbothof these studies, this was not influenced bytheindex test nor did they include these patientsinthefinal analysis. With regard to items 8 and 9, one study did not provide a detailed description of the diagnostic procedures which can increase the variability in the test's performance. Item11refers to blinding and may affect diagnosticaccu-racy leading to potential review bias; inonestudy, it was not clear if the reference test results were blinded. Otherwise, all studiesdemon-strated high-quality scoring on the remaining9items (Fig.2 ) . (Fig. 4) . The stability of ourmodelwas confirmed by the leaveone-outsensitivity analysis which generated pooled estimates close to those obtained with all eligible studies (mean sensitivity 89.0%, range 86.5-92.6%; mean specificity 91.2%, range 86.7-94.0%; meanLR+ 6.2, range 3. 96-8.73 ;m e a n LR 0.21,range 0.14-0.30). Our observation is also limited by the small number of studies available that comparetheaccuracy of TEE for the detection of PFO tocath-eterization, autopsy and/or surgicalfindings.The164 patients that encompassed the studypopu-lation were either severely ill, referred for PFOclo-sure for PFO-related conditions, or hadothercardiac diseases which required surgery.Thiscohort may have been different from the majority of other studies that often include patientswhounderwent TEE after being referred foreitherrecurrent stroke ormigraines.
TEE Diagnostic Value:
In conclusion, our data demonstrates TEEtohave a sensitivity of 0.89 and specificity of0.91for the diagnosis of PFO. The low negative likeli-hood ratio of TEE suggests that it is a proficient test of exclusion forPFO.
